Autologous versus allogeneic transfusions: No difference in perioperative outcome after partial hepatectomy: Autologous transfusion on hepatectomy outcome

Journal of Gastrointestinal Surgery

Volumn 11, Issue 10, 2007, Pages 1286-1293

  Park, James O ^a   Gonen, Mithat ^a   D'Angelica, Michael I ^a   Dematteo, Ronald P ^a   Fong, Yuman ^a   Wuest, David ^a   Blumgart, Leslie H ^a   Jarnagin, William R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Autologous; Hepatectomy; Outcome; Perioperative; Transfusion

Indexed keywords

AGED; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION; COMORBIDITY; COMPARATIVE STUDY; FEMALE; HUMAN; LIVER DISEASE; LIVER RESECTION; LIVER TUMOR; MALE; METHODOLOGY; MIDDLE AGED; TREATMENT OUTCOME;

AGED; BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; COMORBIDITY; FEMALE; HEPATECTOMY; HUMANS; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 34548547427     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-007-0238-4     Document Type: Article

References (35)

1. Billingsley KG, Jarnagin WR, Fong Y, Blumgart LH. Segment-oriented hepatic resection in the management of malignant neoplasms of the liver. J Am Coll Surg 1998;187:471-481.
2. Melendez JA, Arslan V, Fischer ME, Wuest D, Jarnagin WR, Fong Y, Blumgart LH. Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg 1998;187:620-625.
3. Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, Corvera C, Weber S, Blumgart LH. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 2002;236:397-406.
4. Kooby DA, Stockman J, Ben-Porat L, Gonen M, Jarnagin WR, Dematteo RP, Tuorto S, Wuest D, Blumgart LH, Fong Y. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 2003;237:860-869.
5. Blumberg N, Heal JM. Effects of transfusion on immune function. Cancer recurrence and infection. Arch Pathol Lab Med 1994;118:371-379.
6. Blumberg N. Deleterious clinical effects of transfusion immunomodulation: proven beyond a reasonable doubt. Transfusion 2005;45(2 Suppl):33S-39S.
7. Transfusion alert: use of autologous blood. National Heart, Lung, and Blood Institute Expert Panel on the Use of Autologous Blood. Transfusion 1995;35:703-711.
8. Cunningham JD, Fong Y, Shriver C, Melendez J, Marx WL, Blumgart LH. One hundred consecutive hepatic resections. Blood loss, transfusion, and operative technique. Arch Surg 1994;129:1050-1056.
9. Martin RC 2nd, Brennan MF, Jaques DP. Quality of complication reporting in the surgical literature. Ann Surg 2002;235(6):803-813.
10. Dellinger EP, Anaya DA. Infectious and immunologic consequences of blood transfusion. Crit Care 2004;8:S18-S23.
11. Kuehnert MJ, Roth VR, Haley NR, Gregory KR, Elder KV, Schreiber GB, Arduino MJ, Holt SC, Carson LA, Banerjee SN, Jarvis WR. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion 2001;41:1493-1499.
12. Busch MP, Kleinman SH, Nemo GJ. Current and emerging infectious risks of blood transfusions. JAMA 2003;26;289:959-962.
13. Wang B, Schreiber GB, Glynn SA, Nass CC, Smith JW, Higgins MJ, Hutching ST, Wright DJ, McEntire RL, Murphy EL. Retrovirus epidemiology donor study. Prevalence of transfusion-transmissible viral infections in first-time US blood donors by donation site. Transfusion 2003;43:705-712.
14. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The retrovirus epidemiology donor study. N Engl J Med 1996;27;334:1685-1690.
15. Heddle NM, Blajchman MA, Meyer RM et al. A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets. Transfusion 2002;42:556-566.
16. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group. N Engl J Med 1997;25(337):1861-1869.
17. Higgins MJ, Blackall DP. Transfusion-associated graft-versus-host disease: a serious residual risk of blood transfusion. Curr Hematol Rep 2005;4:470-476.
18. Toy P, Popovsky MA, Abraham E, Ambruso DR, Holness LG, Kopko PM, McFarland JG, Nathens AB, Silliman CC, Stroncek D; National Heart, Lung and Blood Institute Working Group on TRALI. Transfusion-related acute lung injury: definition and review. Crit Care Med 2005;33:721-726.
19. Opelz G, Sengar DP, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973;5:253-259.
20. Opelz G, Terasaki PI. Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med 1978;12;299:799-803.
21. Christiansen OB, Nielsen HS, Pedersen B. Active or passive immunization in unexplained recurrent miscarriage. J Reprod Immunol 2004;62:41-52.
22. Blumberg N, Heal JM. Effects of transfusion on immune function. Cancer recurrence and infection. Arch Pathol Lab Med 1994;118:371-379.
23. Vamvakas EC. Pneumonia as a complication of blood product transfusion in the critically ill: transfusion-related immunomodulation (TRIM). Crit Care Med 2006;34:S151-S159.
24. Stephenson KR, Steinberg SM, Hughes KS, Vetto JT, Sugarbaker PH, Chang AE. Perioperative blood transfusions are associated with decreased time to recurrence and decreased survival after resection of colorectal liver metastases. Ann Surg 1988;208:679-687.
25. Hirano T, Yamanaka J, Iimuro Y, Fujimoto J. Long-term safety of autotransfusion during hepatectomy for hepatocellular carcinoma. Surg Today 2005;35:1042-1046.
26. Asahara T, Katayama K, Itamoto T, Yano M, Hino H, Okamoto Y, Nakahara H, Dohi K, Moriwaki K, Yuge O. Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma. World J Surg 1999;23:676-680.
27. Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H, Yamaguchi N, Mizuno S, Makuuchi M. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery 1994;115:303-309.
28. Bordin JO, Bardossy L, Blajchman MA. Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: the importance of the timing of the leukodepletion. Blood 1994;84:344-348.
29. McAlister FA, Clark HD, Wells PS, Laupacis A. Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies. Br J Surg 1998;85:171-178.
30. Itamoto T, Katayama K, Nakahara H, Tashiro H, Asahara T. Autologous blood storage before hepatectomy for hepatocellular carcinoma with underlying liver disease. Br J Surg 2003;90:23-28.
31. Obayashi T, Taniguchi H, Mugitani T, Koh T, Kitagawa K, Kunishima S, Yamaguchi A, Yamagishi H. Safety and utility of autologous blood transfusion for resection of metastatic liver tumor. Hepatogastroenterology 2001;48:812-817.
32. Kitagawa K, Taniguchi H, Mugitani T, Koh T, Kitagawa K, Kunishima S, Yamaguchi A, Yamagishi H. Safety and advantage of perioperative autologous blood transfusion in hepatic resection for hepatocellular carcinoma. Anticancer Res 2001;21:3663-3667.
33. Matot I, Scheinin O, Jurim O, Eid A. Effectiveness of acute normovolemic hemodilution to minimize allogeneic blood transfusion in major liver resections. Anesthesiology 2002;97:794-800.
34. Chen H, Sitzmann JV, Marcucci C, Choti MA. Acute isovolemic hemodilution during major hepatic resection-an initial report: does it safely reduce the blood transfusion requirement? J Gastrointest Surg 1997;1:461-466.
35. Zulim RA, Rocco M, Goodnight JE Jr, Smith GJ, Krag DN, Schneider PD. Intraoperative autotransfusion in hepatic resection for malignancy. Is it safe? Arch Surg 1993;128:206-211.